Arcoma AB

Stockholm Stock Exchange ARCOMA.ST

Arcoma AB Free Cash Flow for the year ending December 31, 2023: USD 1.64 M

Arcoma AB Free Cash Flow is USD 1.64 M for the year ending December 31, 2023, a 494.74% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Arcoma AB Free Cash Flow for the year ending December 31, 2022 was USD -415.23 K, a 38.38% change year over year.
Arcoma AB Free Cash Flow for the year ending December 31, 2021 was USD -673.81 K, a -14.51% change year over year.
Arcoma AB Free Cash Flow for the year ending December 31, 2020 was USD -588.43 K, a -19,651.14% change year over year.
Arcoma AB Free Cash Flow for the year ending December 31, 2019 was USD -2.98 K, a 96.96% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Stockholm Stock Exchange: ARCOMA.ST

Arcoma AB

CEO	Mr. Mattias Leire
IPO Date	Nov. 14, 2014
Location	Sweden
Headquarters	AnnavAegen 1
Employees	32
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was founded in 1990 and is based in Växjö, Sweden.

Key trends

Past 5 years